13.90SEK-0.71%Mkt Cap: 390.95M SEKP/E: —Last update: 2026-06-01
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, a…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap390.95M SEK
Enterprise Value353.00M SEK
Revenue (TTM)286.96M SEK
Gross Profit250.87M SEK
Net Income (TTM)-32.33M SEK
Revenue/Share9.986 SEK
Last Price13.90 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees118
CountrySE
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)20.29
PEG—
EV/EBITDA-19.66
EV/Revenue1.23
P/S1.37
P/B3.17
EPS (TTM)-0.66
EPS (Forward)0.69
52W Range
8.50042% of range21.30
52W High21.30 SEK
52W Low8.500 SEK
Profitability
Gross Margin89.89%
Oper. Margin-31.09%
EBITDA Margin-6.25%
Profit Margin-11.59%
ROE-23.37%
ROA-10.36%
Growth
Revenue Growth14.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-20.30M SEK
CapEx (TTM)15.46M SEK
FCF Margin-2.73%
FCF Yield-2.01%
Net Debt-40.76M SEK
Net Debt/EBITDA2.27
Balance Sheet
Debt/Equity0.12
Current Ratio0.99
Quick Ratio0.79
Book Value/Sh4.419 SEK
Cash/Share1.999 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)21.00 SEK
Target Range13.50 SEK – 28.50 SEK
# Analysts2
Ownership
Shares Out.28.13M
Float4.52M
Insiders50.96%
Institutions28.08%
Technical
SMA 5013.56 (+2.5%)
SMA 20013.03 (+6.7%)
Beta0.46
S&P 52W Chg27.70%
Avg Vol (30d)23.45K
Avg Vol (10d)10.57K
Technical Indicators
RSI (14)48.7
MACD0.4053
MACD Signal0.4396
MACD Hist.-0.0343
BB Upper16.40 SEK
BB Middle14.06 SEK
BB Lower11.73 SEK
BB Width33.18%
ATR (14)0.6392 SEK
Vol Ratio (20d)0.28x